Tirzepatide Prescribing at NORTH HOUSE SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
1,060
Total Quantity
1,080
NHS Cost
£101.3K
vs National Avg
+445.8%
NORTH HOUSE SURGERY prescribed 1,060 items of Tirzepatide over the last 12 months at a cost of £101,347 to the NHS. This is 445.8% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
27
Jul 2026
48
Jul 2026
65
Jul 2026
74
Jul 2026
67
Jul 2026
93
Jul 2026
96
Jul 2026
117
Jul 2026
118
Jul 2026
107
Jul 2026
110
Jul 2026
138
Prescribing Details
| Total Items | 1,060 |
|---|---|
| Total Quantity | 1,080 |
| Total NHS Cost | £101,347 |
| Presentations | 9 different forms |
| vs National Average | +445.8% |
Tirzepatide Prescribing Comparison
| This practice | 1,060 items |
|---|---|
| National average per practice | 194 items |
| Difference | +445.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.